At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Herpesvirus infections
Most Recent Events
- 28 Sep 1998 Discontinued-Preclinical for Herpesvirus infections in United Kingdom (Unknown route)
- 05 Aug 1998 No-Development-Reported for Herpesvirus infections in United Kingdom (Unknown route)